NCEL

$2.37-0.08 (-3.27%)

Market ClosedAs of Mar 20, 8:00 PM UTC

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPROTranscriptsPROStatementsPRO

Recent News

Simply Wall St.
Nov 1, 2025

Owning 58% in NewcelX Ltd. (NASDAQ:NCEL) means that insiders are heavily invested in the company's future

Key Insights NewcelX's significant insider ownership suggests inherent interests in company's expansion 58% of the...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.